Pea F - Search Results

1

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data.

Giacobbe DR, Ciacco E, Girmenia C, Pea F, Rossolini GM, Sotgiu G, Tascini C, Tumbarello M, Viale P, Bassetti M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Italian Society of Anti-infective Therapy). Giacobbe DR, et al. Among authors: pea f. Infect Drug Resist. 2020 Dec 29;13:4697-4711. doi: 10.2147/IDR.S205309. eCollection 2020. Infect Drug Resist. 2020. PMID: 33402840 Free PMC article. Review.

2

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.

Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Pea F, et al. J Antimicrob Chemother. 2003 Apr;51(4):971-5. doi: 10.1093/jac/dkg147. Epub 2003 Feb 25. J Antimicrob Chemother. 2003. PMID: 12654757

3

Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?

Pea F, Viale P, Furlanut MI. Pea F, et al. J Chemother. 2003 Feb;15(1):3-11. doi: 10.1179/joc.2003.15.Supplement-2.3. J Chemother. 2003. PMID: 12678408 Review.

4

[What role for fluoroquinolones in intensive therapy?].

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Aug;15 Suppl 1:5-10. J Chemother. 2003. PMID: 14535066 Review. Italian. No abstract available.

5

What is the role of fluoroquinolones in intensive care?

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Nov;15 Suppl 3:5-10. doi: 10.1080/1120009x.2003.11782356. J Chemother. 2003. PMID: 14708959 Review.

6

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Pea F, Viale P, Furlanut M. Pea F, et al. Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.

7

The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?

Pea F, Viale P. Pea F, et al. Clin Infect Dis. 2006 Jun 15;42(12):1764-71. doi: 10.1086/504383. Epub 2006 May 10. Clin Infect Dis. 2006. PMID: 16705585 Review.

8

Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.

Pea F, Poz D, Viale P, Pavan F, Furlanut M. Pea F, et al. J Antimicrob Chemother. 2006 Aug;58(2):380-6. doi: 10.1093/jac/dkl226. Epub 2006 May 30. J Antimicrob Chemother. 2006. PMID: 16735422

9

Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.

Pea F, Viale P. Pea F, et al. Expert Rev Anti Infect Ther. 2007 Apr;5(2):255-70. doi: 10.1586/14787210.5.2.255. Expert Rev Anti Infect Ther. 2007. PMID: 17402840 Review.

10

What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?

Viale P, Pea F. Viale P, et al. Among authors: pea f. Crit Care Med. 2007 Mar;35(3):991; author reply 991-2. doi: 10.1097/01.ccm.0000257473.18308.64. Crit Care Med. 2007. PMID: 17421115 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters